UFP Technologies, Inc. — Earnings Quality Grade F
UFPT · Healthcare
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 50 days, change -11 days YoY
AR growth -2.1% vs revenue growth 19.5%
Revenue 19.5%, CFFO 38.0%. Cash follows revenue
Expense Quality
Inventory -0.8% vs COGS 20.9%. Normal
CapEx growth 33.9% vs revenue 19.5%. Normal
SG&A/Gross Profit = 45.4%. Normal
Gross margin 28.3%, change -0.8pp. Stable
Cash Flow Quality
CFFO/NI = 1.35. Profits backed by cash
FCF $0.1B, FCF/NI = 1.16
Accruals ratio = -3.6%. Low accruals
Cash $0.0B covers only 13% of debt $0.2B
Balance Sheet Health
Goodwill+Intangibles $0.3B = 80% of equity. Over 50%
Debt/EBITDA = 1.4x. Healthy
Other assets grew 670.5% vs revenue 19.5%
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change 1% YoY. Normal
Manipulation Score
M-Score = -2.57 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor UFPT continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25